E3 PreliminaryPreliminaryPEM unclearReview-NarrativePeer-reviewedMachine draft
[Post-COVID neurological sequelae, proposed mechanisms and therapeutic approaches].
Slama Schwok, Anny · Medecine sciences : M/S · 2026 · DOI
Quick Summary
This review examines the long-term neurological effects that some people experience after COVID-19 infection, affecting about 5% of patients. The symptoms include brain fog, chronic fatigue, anxiety, depression, and nerve inflammation, which significantly impact daily life. The authors examine the underlying biological mechanisms—such as brain inflammation, disrupted brain chemistry, immune dysfunction, and blood vessel problems—that may cause these symptoms to help guide future treatments.
Why It Matters
Understanding the biological mechanisms driving post-COVID neurological symptoms is critical for developing targeted treatments, as these patients—many of working age with female predominance—experience substantial quality-of-life impairment. This work directly parallels ME/CFS research priorities, as post-COVID neurological sequelae share symptom overlap with ME/CFS, making mechanistic insights relevant to both conditions.
Observed Findings
- Approximately 5% of COVID-19 patients develop persistent neurological sequelae
- Women are disproportionately affected by post-COVID neurological complications
- Most common symptoms include cognitive impairment ('brain fog'), chronic fatigue, anxiety, depression, and nervous system inflammation
- Persistent neurological symptoms significantly reduce quality of life and work capacity in primarily young to middle-aged adults (18-50 years)
Inferred Conclusions
- Neuroinflammation, neurotransmission dysfunction, and immune/endothelial/microvascular impairment are proposed pathological mechanisms in Long neuro-COVID
- Clarity on underlying pathological mechanisms is essential for developing effective therapeutic approaches
- Post-COVID neurological sequelae represent a significant societal health need requiring urgent research and treatment development
Remaining Questions
- Which specific neuroinflammatory pathways are most significant in post-COVID neurological disease, and how do they differ from those in ME/CFS?
- What are the most promising therapeutic interventions based on these proposed mechanisms, and which merit clinical trial evaluation?
- Why are women disproportionately affected, and are there sex-specific biological mechanisms driving this difference?
What This Study Does Not Prove
This is a literature review, not a primary research study, so it cannot prove any new biological findings itself—it synthesizes existing work. The review does not establish causation for any proposed mechanisms, only correlation and theoretical plausibility based on previously published studies. The abstract does not specify which studies were included or excluded, limiting assessment of the evidence base strength.
Tags
Symptom:Cognitive DysfunctionFatigue
Biomarker:CytokinesNeuroimaging
Phenotype:Infection-TriggeredLong COVID Overlap
Method Flag:PEM Not DefinedWeak Case Definition
Metadata
- DOI
- 10.1051/medsci/2026036
- PMID
- 41860269
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →